It has proved difficult to develop biosimilars of the antibody due to its structural complexity. “With our expertise in the treatment of CRC, and based on the encouraging early data for ...
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety and efficacy after being switched to another ranibizumab biosimilar, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback